20
Embio Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is EPHEDRINE SULFATE USP, with a corresponding US DMF Number 32697.
Remarkably, this DMF maintains an Active status since its submission on April 17, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 19, 2018, and payment made on April 17, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II